Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies.

Mesa, Ra; Kiladjian, Jj; Verstovsek, S; Al Ali HK,; Gotlib, J; Gisslinger, H; Levy, R; Siulnik, A; Gupta, V; Khan, M; Dipersio, Jf; Mcquitty, M; Catalano, Jv; Hunter, Ds; Knoops, L; Deininger, M; Cervantes, F; Miller, C; Vannucchi, ALESSANDRO MARIA; Silver, Rt; Barbui, T; Talpaz, M; Barosi, G; Winton, Ef; Mendeson, E; Harvey JH Jr,; Arcasoy, Mo; Hexner, E; Lyons, Rm; Paquette, R; Raza, A; Sun, W; Sandor, V; Kantarjian, Hm; Harrison, C.

doi:10.3324/haematol.2013.087650

analisi di confrontro tra due regimi di terapia convenzinale in due studi di fase 3 con inibitore di JAK2

Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies / Mesa RA;Kiladjian JJ;Verstovsek S;Al-Ali HK;Gotlib J;Gisslinger H;Levy R;Siulnik A;Gupta V;Khan M;DiPersio JF;McQuitty M;Catalano JV;Hunter DS;Knoops L;Deininger M;Cervantes F;Miller C;Vannucchi AM;Silver RT;Barbui T;Talpaz M;Barosi G;Winton EF;Mendeson E;Harvey JH Jr;Arcasoy MO;Hexner E;Lyons RM;Paquette R;Raza A;Sun W;Sandor V;Kantarjian HM;Harrison C. - In: HAEMATOLOGICA. - ISSN 0390-6078. - STAMPA. - 99:(2014), pp. 292-298. [10.3324/haematol.2013.087650]